MIB‐1 Proliferation Index in Ductal Carcinoma In Situ of the Breast: Relationship to the Expression of the Apoptosis‐Regulating Proteins bcl‐2 and p53

No abstract is available for this paper.

• Publication year

  2000

• Venue

  The Breast Journal

• Publication date

  2000-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1524-4741.2000.99088.xPMID 11348399
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell kinetics of histologic variants ofin situ breast carcinoma

  2005cited by this paper
• Treatment of early-stage breast cancer.

  1999cited by this paper
• Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas.

  1998cited by this paper
• Bcl-2 oncoprotein positivity and high MIB-1 (Ki-67) proliferative rate are independent predictive markers for recurrence in prostate carcinoma.

  1998cited by this paper
• Cell proliferation rate by MIB-1 immunohistochemistry predicts postradiation recurrence in prostatic adenocarcinomas.

  1998cited by this paper
• Utility of Ki-67 as a prognostic marker in pancreatic endocrine neoplasms.

  1998cited by this paper
• Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium.

  1998cited by this paper
• Somatic Frameshift Mutations in the BAX Gene in Colon Cancers of the Microsatellite Mutator Phenotype

  1997cited by this paper
• Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67.

  1997cited by this paper
• p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast.

  1997cited by this paper
• Bax suppresses tumorigenesis and stimulates apoptosis in vivo

  1997cited by this paper
• Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas.

  1996cited by this paper
• bcl-2 expression in the spectrum of preinvasive breast lesions.

  1996influential reference
• Relationship between p53 gene abnormalities and other tumour characteristics in breast‐cancer prognosis

  1996cited by this paper
• Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2.

  1995cited by this paper
• Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.

  1995cited by this paper
• Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.

  1995cited by this paper
• Cortical Architectural Abnormalities and MIB1 Immunoreactivity in Gangliogliomas: A Study of 60 Patients with Intracranial Tumors

  1995cited by this paper
• Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2.

  1995cited by this paper
• Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1.

  1995cited by this paper
• Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparison with Ki‐67 antibody

  1994cited by this paper
• bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer.

  1994cited by this paper
• The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

  1994cited by this paper
• Ductal carcinoma in situ: a proposal for a new classification.

  1994cited by this paper
• Down-regulation of bcl-2 by p53 in breast cancer cells.

  1994cited by this paper
• Bcl-2 protein expression and long-term survival in breast cancer.

  1994cited by this paper
• Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis.

  1994cited by this paper
• Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2.

  1994cited by this paper
• Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.

  1994cited by this paper
• MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management

  1994cited by this paper
• Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity.

  1994cited by this paper
• Apoptosis. Its significance in cancer and cancer Therapy

  1994cited by this paper
• Apoptosis in cancer therapy: crossing the threshold.

  1994cited by this paper
• Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity.

  1994cited by this paper
• Cellular proliferation and prognosis in breast cancer: statistical purity versus clinical utility.

  1994cited by this paper
• Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody.

  1994cited by this paper
• Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections

  1992cited by this paper
• BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.

  1991cited by this paper
• Adjuvant therapy for node‐negative breast cancer: The use of prognostic factors in selecting patients

  1991cited by this paper
• The role of chemotherapy for node‐negative breast cancer

  1991cited by this paper
• Should all patients with node‐negative breast cancer receive adjuvant therapy? Identifying additional subsets of low‐risk patients who are highly curable by surgery alone

  1991cited by this paper
• The relationship of nasopharyngeal carcinomas and second independent malignancies based on the radiation therapy oncology group experience

  1991cited by this paper
• How to use prognostic factors in axillary node-negative breast cancer patients.

  1990cited by this paper
• Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

  1984cited by this paper
• Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

  1983cited by this paper

• P53, HER2/neu, Bcl-2 and PCNA overexpression in ductal carcinoma in situ lesions of the breast and their role in progression to invasive carcinoma

  2019cites this paper
• The Progression of Pre-invasive to Invasive Cancer

  2011cites this paper
• Alterations of p53, BCL‐2, and hMSH2 protein expression in the normal brain tissues, gliosis, and gliomas

  2006cites this paper
• Correlations in survivin expression with the expression of p53 and bcl-2 in invasive ductal carcinoma of the breast.

  2006cites this paper
• Correlation of HER2 Gene Amplification With Expression of the Apoptosis-Suppressing Genes bcl-2 and bcl-x-L in Ductal Carcinoma in Situ of the Breast

  2005cites this paper
• Alterations of p53 and Bcl-2 protein expression in the laryngeal intraepithelial neoplasia

  2005cites this paper
• Clinical Approaches to Discovering and Testing New Breast Cancer Prevention Drugs

  2005cites this paper
• Molecular Mechanisms of Breast Cancer Progression: Lessons from Mouse Mammary Cancer Models and Gene Expression Profiling

  2004cites this paper
• Alterations of p53, Bcl-2, and hMSH2 protein expression in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas in the upper egypt

  2004cites this paper
• EGFR, HER-2/neu, Cyclin D1, p21 and p53 in Correlation to Cell Proliferation and Steroid Hormone Receptor Status in Ductal Carcinoma in situ of the Breast

  2003cites this paper
• Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept

  2003cites this paper
• Molecular markers and therapeutic targets in ductal carcinoma in situ

  2002cites this paper
• Common Adult Stem Cells in the Human Breast Give Rise to Glandular and Myoepithelial Cell Lineages: A New Cell Biological Concept

  2002cites this paper
• A working model for the time sequence of genetic changes in breast tumorigenesis.

  2002cites this paper